How much funding has healthOme raised?

healthOme has disclosed $9.9M raised across 2 rounds.

Where is healthOme headquartered?

healthOme is headquartered in Huntsville, US.

healthOme

Huntsville, US · Founded 2021 · Delaware corporation

HealthHome offers Kadance, a precision cancer management service that combines genomic science with expert health navigation to help individuals with cancer risk assessment, treatment planning, and recovery. It is sold to individuals as well as insurance carriers and agents as an add-on to critical illness or life insurance policies.

BiotechDigital HealthHealthtech

Founders & leadership

David StertzerExecutive

Camilo MoncadaExecutive

Terri KinlochExecutive

Kimberly ScottExecutive

Board

Spencer TallBoard director

Brittany ClementsBoard director

Anne Melissa DowlingBoard director

Reported raises · per SEC filings

Form D private placements

$9.9M disclosed across 2 rounds · 2023–2024

▶$2MraisedDec 2024 · 2 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

David StertzerExecutive Officer, Director
Brittany ClementsDirector
Spencer TallDirector
Anne Melissa DowlingDirector
Camilo MoncadaExecutive Officer
Terri KinlochExecutive Officer
Kimberly ScottExecutive Officer

Offering amount: $2M
Amount sold: $2M
Proceeds to insiders: $925K
First sale: Nov 2024
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$7.9MraisedMay 2024 · 10 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Spencer TallDirector
Brittany ClementsDirector
Terri KinlochExecutive Officer
Anne Melissa DowlingDirector
Camilo MoncadaExecutive Officer
David StertzerExecutive Officer, Director
Kimberly ScottExecutive Officer

Offering amount: $8.4M
Amount sold: $7.9M
Minimum investment: $100K
Proceeds to insiders: $925K
First sale: Nov 2023
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 10

by search overlap

Myome22 shared keywordsMyOme uses whole genome sequencing and bioinformatics to analyze a single patient sample and produce clinically actionable reports, offering both proactive health tests (such as polygenic risk scores and medication response) and diagnostic tests for rare disease. Its genomic testing serves healthcare providers, patients, employers, and health systems to guide prevention, treatment, and lifestyle decisions.

Immunome21 shared keywordsImmunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer. It also acquires targeted oncology assets and advances them through manufacturing and clinical development.

OneOme20 shared keywordsOneOme provides pharmacogenomic (PGx) products and services, centered on its RightMed Test that analyzes a patient's DNA to inform medication decisions. It serves health systems, payers, PBMs, employers, providers, and pharmacists with clinical consults, EHR integration, and population health tools.

Alterome Therapeutics, Inc.19 shared keywordsAlterome develops targeted, genomically-defined cancer therapies aimed at aggressive cancers that lack effective treatment options, focusing on more precise drugs with fewer off-target effects. It serves cancer patients by targeting disease-driving genetic alterations.

Noveome Biotherapeutics18 shared keywordsNoveome is a biopharmaceutical company developing ST266, a multi-targeted secretome biologic containing biologically active proteins and factors aimed at neuroprotection, inflammation modulation, and cell recovery. The company is targeting underserved conditions in ophthalmology, neurology, and dermatology.

Genomeweb17 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.

Freenome16 shared keywordsFreenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases. The company serves healthcare providers and patients seeking preventive cancer screening solutions.

Nucleome13 shared keywordsNucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets. The company builds a data atlas of immune system dysregulation to enable development of genetically-informed therapeutics for inflammatory conditions.

Sensome11 shared keywordsSensome develops a microchip-based tissue-sensing technology that embeds bio-impedance sensors into minimally invasive medical devices to give physicians real-time, patient-specific data during procedures. Its lead product, the Clotild Smart Guidewire System, provides real-time blood clot characterization for acute ischemic stroke treatment, with additional applications in lung cancer biopsy and peripheral vascular intervention.

Inside Precision Medicine10 shared keywordsInside Precision Medicine is a news and media outlet covering precision medicine, oncology, genomics, diagnostics, and translational research. It publishes articles, webinars, and a podcast series aimed at researchers and professionals in the precision medicine field.

Companies competing with healthOme for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does healthOme do?: HealthHome offers Kadance, a precision cancer management service that combines genomic science with expert health navigation to help individuals with cancer risk assessment, treatment planning, and recovery. It is sold to individuals as well as insurance carriers and agents as an add-on to critical illness or life insurance policies.
How much funding has healthOme raised?: healthOme has disclosed $9.9M raised across 2 rounds.
Where is healthOme headquartered?: healthOme is headquartered in Huntsville, US.